Compare KURA & STK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KURA | STK |
|---|---|---|
| Founded | 2014 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 830.1M | 694.8M |
| IPO Year | N/A | N/A |
| Metric | KURA | STK |
|---|---|---|
| Price | $8.35 | $39.79 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $26.88 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 38.2K |
| Earning Date | 02-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.60% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $104,029,000.00 | N/A |
| Revenue This Year | $88.72 | N/A |
| Revenue Next Year | $68.75 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.41 | $24.95 |
| 52 Week High | $12.49 | $34.31 |
| Indicator | KURA | STK |
|---|---|---|
| Relative Strength Index (RSI) | 44.59 | 53.41 |
| Support Level | $7.50 | $38.00 |
| Resistance Level | $8.08 | $41.17 |
| Average True Range (ATR) | 0.34 | 1.09 |
| MACD | 0.07 | -0.09 |
| Stochastic Oscillator | 68.99 | 55.78 |
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
Columbia Seligman Premium Technology Growth Fund Inc is a closed-end management investment company. Its investment objective is to seek growth of capital and current income. The fund invests in various sectors such as consumer discretionary, industrials, information technology and telecommunication services. Columbia Management Investment Advisers, LLC serves as the investment manager to the fund.